Urine Adiponectin Concentration in Prediction of Contrast Induced Nephropathy

NCT01372891 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2011-11-22

No results posted yet for this study

Summary

The present study is to determine the ability of urinary total adiponectin and its isoforms excretion in the prediction of contrast induced nephropathy (CIN) in the patients undergoing PCI.

Conditions

  • Myocardial Ischemia

Sponsors & Collaborators

  • Xijing Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2013-04-30
Completion
2014-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01372891 on ClinicalTrials.gov